Clinical Trials Logo

Filter by:
NCT ID: NCT00526006 Recruiting - Healthy Clinical Trials

PPI-Rebound-Trial. A Study of the Clinical Relevance of the Acid Rebound Phenomena

Start date: September 2007
Phase: Phase 4
Study type: Interventional

The acid secretion in the stomach seems to increase after withdrawal of min. 8 wks of treatment with a PPI (protonpump inhibitor) It is unknown if this acid rebound phenomenon is of clinical significance. In a doubleblinded and placebocontrolled study healthy volunteers are randomized to treatment with placebo or PPI + placebo. Gastrointestinal symptoms are scored once a week and.

NCT ID: NCT00524602 Recruiting - Arrythmia Clinical Trials

The Use of Remote Magnetic Navigation in Catheter Ablation of Heart Arrythmia

Start date: June 2007
Phase: N/A
Study type: Interventional

Patients with several heart arrythmia can potentially be cured by catheterablation. For some arrythmias 95% of the patients are cured. Also patients with atrial fibrillation are cured by catherablation even though the effect is not as impressive as for other cardiac arrythmias. About 70% of patients with paroxystic and persistant atrial fibrillation are cured. Most of the remaining obtain a reduction of their symptoms. At conventional ablation of atrial fibrillation the catheters are manually navigated to the ideal anatomic position where to isolate the pulmonary veins from the left atrium. Lately it has been possible to navigate the ablationcatheters using 'remote magnetic navigation' using a magnetic based navigation equipment, Stereotaxis. The Heartcentre of Rigshospitalet had this Stereotaxis equipment installed in the autumn of 2006. We will investigate the utility and safety of using this remote magnetic navigation/Stereotaxis.

NCT ID: NCT00519909 Recruiting - Obesity Clinical Trials

The Effect of Calcium on Fecal Fat and Energy Excretion

Start date: August 2007
Phase: N/A
Study type: Interventional

The overall purpose of this study is to examine the effect of calcium on fecal fat and energy excretion.

NCT ID: NCT00510172 Recruiting - Migraine Clinical Trials

Migraine Inducing Effects and Changes in Brain Haemodynamics of PGI2

Start date: December 2006
Phase: N/A
Study type: Interventional

We hypothesised that intravenous infusion of PGI2 induced headache or migraine and cranial vasodilatation in migraineurs.

NCT ID: NCT00463411 Recruiting - Osteoporosis Clinical Trials

Study of Male Osteoporosis and Aging

Start date: December 2006
Phase: N/A
Study type: Observational

The aim of this study is to identify potential risk factors for fragility fractures in men.

NCT ID: NCT00451984 Recruiting - HIV Infections Clinical Trials

Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2

HEPVACHIV
Start date: March 2007
Phase: Phase 3
Study type: Interventional

The response to vaccination for hepatitis is reduced in patients with HIV infection. The hypothesis of the study is that adjuvant interleukin-2 administered subcutaneously at the time of vaccination improves the response rate.

NCT ID: NCT00442143 Recruiting - Ischemia Clinical Trials

Treatment of Severe Limb Ischemia With Autologous Bonemarrow Derived Mononuclear Cells

DANCELL-CLI
Start date: January 2007
Phase: Phase 1
Study type: Interventional

The aim of the study is to investigate whether implantation of autologous bone marrow derived stem cells in ishemics limbs will improve vascularization

NCT ID: NCT00435422 Recruiting - Hypovolemia Clinical Trials

Neuroaxial Blokade and Blood Pressure

Start date: January 2010
Phase: N/A
Study type: Interventional

The effect of individualized fluid optimization during neuroaxial blockade has not been evaluated. The investigators evaluated if if Stroke decrease 15 min after activation of neuroaxial blockade and whether SV could be optimized to pre activation values.

NCT ID: NCT00431262 Recruiting - Alcoholism Clinical Trials

Antabuse in Severe Alcoholism: an Open Controlled Study

Start date: February 2007
Phase: Phase 4
Study type: Interventional

Newly detoxified alcoholics (N=60) are randomised to either antabuse (disulfiram) treatment or the control group for a total of 6 months.All patients will receive cognitive behavioural treatment in groups. The hypothesis to be tested is that more of the patients who receive antabuse (disulfiram) will be alcohol free during the 6 months treatment period compared to the control group. The trial is open.

NCT ID: NCT00430001 Recruiting - Breast Cancer Clinical Trials

Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast Cancer

Start date: May 2005
Phase: Phase 3
Study type: Interventional

In an open-label randomised phase III-trial patients with metastatic HER2-positive breast cancer naive to chemotherapy with normal organ function and WHO performance status < 3 are randomised to receive either docetaxel 100 mg/m2 i.v. plus trastuzumab 6 mg/kg (8 mg/kg loading dose) q 3 weeks or vinorelbine 30 or 35 mg/m2 days 1+8 plus trastuzumab 6 mg/kg (8 mg/kg loading dose) q 3 weeks. Primary endpoint is time to progression. Secondary endpoints include overall survival, time to treatment failure, response rate, duration of response and toxicity. The study hypothesis is that docetaxel is more efficient than vinorelbine but also more toxic.